119 related articles for article (PubMed ID: 8132444)
1. Up-regulation of 5-HT2 serotonin receptor: a possible mechanism of transformed migraine.
Srikiatkhachorn A; Govitrapong P; Limthavon C
Headache; 1994 Jan; 34(1):8-11. PubMed ID: 8132444
[TBL] [Abstract][Full Text] [Related]
2. 5-HT2 serotonin receptor on blood platelet of migraine patients.
Govitrapong P; Limthavon C; Srikiatkhachorn A
Headache; 1992 Nov; 32(10):480-4. PubMed ID: 1468904
[TBL] [Abstract][Full Text] [Related]
3. Serotonin receptor adaptation in patients with analgesic-induced headache.
Srikiatkhachorn A; Anthony M
Cephalalgia; 1996 Oct; 16(6):419-22. PubMed ID: 8902250
[TBL] [Abstract][Full Text] [Related]
4. Plasticity of 5-HT serotonin receptor in patients with analgesic-induced transformed migraine.
Srikiatkhachorn A; Puangniyom S; Govitrapong P
Headache; 1998; 38(7):534-9. PubMed ID: 15613170
[TBL] [Abstract][Full Text] [Related]
5. Platelet 3H ketanserin binding in migraine.
Shukla R; Khanna VK; Pradeep S; Husain M; Tandon R; Nag D; Dikshit M; Srimal RC; Seth PK
Cephalalgia; 2001 Jun; 21(5):567-72. PubMed ID: 11472383
[TBL] [Abstract][Full Text] [Related]
6. Migraine, serum serotonin and platelet 5-HT2 receptors.
Ribeiro CA; Cotrim MD; Morgadinho MT; Ramos MI; Santos ES; de Macedo Tdos R
Cephalalgia; 1990 Oct; 10(5):213-9. PubMed ID: 2272090
[TBL] [Abstract][Full Text] [Related]
7. Platelet dopamine: D2 receptor binding in patients with migraine.
Shukla R; Khanna VK; Vinod P; Sankhwar ML; Yadav RS
Cephalalgia; 2009 May; 29(5):532-8. PubMed ID: 19170695
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical changes of the serotonergic system in migraine pathobiology.
Gasparini CF; Smith RA; Griffiths LR
J Headache Pain; 2017 Dec; 18(1):20. PubMed ID: 28194570
[TBL] [Abstract][Full Text] [Related]
9. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
Headache; 2015; 55(7):984-91. PubMed ID: 26129705
[TBL] [Abstract][Full Text] [Related]
10. Increased serotonin transporter availability in the brainstem of migraineurs.
Schuh-Hofer S; Richter M; Geworski L; Villringer A; Israel H; Wenzel R; Munz DL; Arnold G
J Neurol; 2007 Jun; 254(6):789-96. PubMed ID: 17351723
[TBL] [Abstract][Full Text] [Related]
11. In vitro interactions of serotonin (5-HT) with mononuclear cells from migraine patients: alterations related to the phase of the attack.
Martelletti P; Alteri E; Pesce A; Rinaldi-Garaci C; Giacovazzo M
J Neuroimmunol; 1988 Apr; 18(1):17-24. PubMed ID: 3346368
[TBL] [Abstract][Full Text] [Related]
12. Migraine patients show increased platelet vasopressin receptors.
Buschmann J; Leppla-Wollsiffer G; Nemeth N; Nelson K; Kirsten R
Headache; 1996; 36(10):586-8. PubMed ID: 8990597
[TBL] [Abstract][Full Text] [Related]
13. Influence of lipid peroxidation on [3H]ketanserin binding to 5-HT2 prefrontal cortex receptors.
Rego AC; Oliveira CR
Neurochem Int; 1995 Dec; 27(6):489-96. PubMed ID: 8574178
[TBL] [Abstract][Full Text] [Related]
14. Derangement of serotonin system in migrainous patients with analgesic abuse headache: clues from platelets.
Srikiatkhachorn A; Maneesri S; Govitrapong P; Kasantikul V
Headache; 1998 Jan; 38(1):43-9. PubMed ID: 9505003
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
16. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
17. Serotonin 5-HT2 receptor binding on blood platelets--a peripheral marker for depression?
Biegon A; Weizman A; Karp L; Ram A; Tiano S; Wolff M
Life Sci; 1987 Nov; 41(22):2485-92. PubMed ID: 3683087
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2 receptor antagonists and migraine therapy.
Mylecharane EJ
J Neurol; 1991; 238 Suppl 1():S45-52. PubMed ID: 2045831
[TBL] [Abstract][Full Text] [Related]
19. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
20. [Migraine, serotonin and serotonergic receptors].
Pascual J
Neurologia; 1993; 8(6):180-3. PubMed ID: 8394726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
